NCT05047172

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2022-08-02Est. Completion: 2027-01-31

Enrollment target: 1,683 participants

Locations

University of Alabama Hospital, Birmingham, Alabama, United States
University of South Alabama University Hospital, Mobile, Alabama, United States
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Mercy San Juan Medical Center, Carmichael, California, United States
The Neuron Clinic - Chula Vista, Chula Vista, California, United States
Kaiser Permanente Fontana Medical Center, Fontana, California, United States
Long Beach Memorial Medical Center, Long Beach, California, United States
Los Alamitos Medical Center, Los Alamitos, California, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Ronald Reagan UCLA Medical Center, Los Angeles, CA, Los Angeles, California, United States
UC Irvine Medical Center, Orange, California, United States
UC Davis Medical Center, Sacramento, California, United States
Salinas Valley Memorial Hospital, Salinas, California, United States
UCSD Medical Center - Hillcrest Hospital, San Diego, California, United States
Providence Little Company of Mary Medical Center Torrance, Torrance, California, United States

Mild Cognitive DisorderAlzheimer DiseaseVascular DementiaDementia in Other Diseases Classified ElsewhereUnspecified Dementia

Around 57 million people worldwide live with dementia, with approximately 10 million new cases diagnosed each year. By t…

Aschaffenburg, GermanyEst. completion Dec 31, 2031

Cardiac Rhythm DisordersUrological DisordersNeurological DisordersCardiovascular DisordersDigestive Disorders

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.